Israel Englander Cerus Corp Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cerus Corp stock. As of the latest transaction made, Millennium Management LLC holds 3,222,327 shares of CERS stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,222,327

Previous 2,877,932 11.97%

Holding current value

$4.16 Million

Previous $4.43 Million 1.06%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.39 - $2.15 $478,709 - $740,449	344,395 Added 11.97%	3,222,327 $4.48 Million
Q4 2024 Feb 14, 2025	BUY	$1.52 - $2.03 $1.5 Million - $2 Million	986,286 Added 52.14%	2,877,932 $4.43 Million
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.39 $741,259 - $1.04 Million	436,035 Added 29.96%	1,891,646 $3.29 Million
Q2 2024 Aug 14, 2024	BUY	$1.62 - $2.04 $1.31 Million - $1.65 Million	806,941 Added 124.4%	1,455,611 $2.56 Million
Q1 2024 May 15, 2024	SELL	$1.66 - $2.42 $3.41 Million - $4.96 Million	-2,051,545 Reduced 75.98%	648,670 $1.23 Million
Q4 2023 Feb 14, 2024	BUY	$1.25 - $2.35 $2.16 Million - $4.07 Million	1,730,162 Added 178.36%	2,700,215 $5.83 Million
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $971,633 - $1.57 Million	-542,812 Reduced 35.88%	970,053 $2.39 Million
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $2.19 Million - $3.15 Million	827,704 Added 120.8%	1,512,865 $4.49 Million
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $2.09 Million - $2.61 Million	-618,010 Reduced 47.42%	685,161 $2.5 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $599,042 - $1.02 Million	174,648 Added 15.48%	1,303,171 $4.69 Million
Q2 2022 Aug 15, 2022	SELL	$4.41 - $5.69 $1.8 Million - $2.32 Million	-408,240 Reduced 26.56%	1,128,523 $5.97 Million
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $590,903 - $858,714	122,849 Added 8.69%	1,536,763 $8.44 Million
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $8.44 Million - $11.2 Million	1,413,914 New	1,413,914 $9.63 Million
Q3 2021 Nov 15, 2021	SELL	$4.79 - $6.68 $71,883 - $100,246	-15,007 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $20,688 - $24,555	3,867 Added 34.71%	15,007 $89,000
Q1 2021 May 17, 2021	SELL	$5.68 - $7.87 $1.66 Million - $2.3 Million	-292,117 Reduced 96.33%	11,140 $67,000
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $586,787 - $956,742	111,769 Added 58.37%	303,257 $2.1 Million
Q3 2020 Nov 16, 2020	SELL	$5.78 - $7.47 $1.25 Million - $1.62 Million	-216,916 Reduced 53.11%	191,488 $1.2 Million
Q2 2020 Aug 14, 2020	SELL	$4.5 - $7.02 $7.04 Million - $11 Million	-1,565,469 Reduced 79.31%	408,404 $2.7 Million
Q1 2020 May 14, 2020	BUY	$2.87 - $5.49 $5.48 Million - $10.5 Million	1,910,994 Added 3039.16%	1,973,873 $9.18 Million
Q4 2019 Feb 14, 2020	BUY	$3.84 - $4.86 $241,455 - $305,591	62,879 New	62,879 $265,000
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $5.53 Million - $8.09 Million	-1,226,381 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.16 - $6.85 $211,425 - $280,671	-40,974 Reduced 3.23%	1,226,381 $7.64 Million
Q4 2018 Feb 14, 2019	BUY	$4.89 - $7.16 $3.36 Million - $4.91 Million	686,333 Added 118.13%	1,267,355 $6.43 Million
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $4.38 Million - $4.95 Million	-635,673 Reduced 52.25%	581,022 $4.19 Million
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $2.72 Million - $3.8 Million	-523,703 Reduced 30.09%	1,216,695 $8.12 Million
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $3.15 Million - $5.09 Million	886,056 Added 103.71%	1,740,398 $9.54 Million
Q4 2017 Feb 14, 2018	BUY	$2.76 - $3.95 $2.36 Million - $3.37 Million	854,342	854,342 $2.89 Million

Others Institutions Holding CERS

# of Institutions

165

Shares Held

146M

Call Options Held

24.2K

Put Options Held

44.4K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $228M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account